Integris
INTEGRIS Pharma is a rapidly growing Greek pharmaceutical company. Founded in 2008 as a CNS generics pharmaceutical company, it successfully relaunched its business model in 2018 with a clear mission to address the unmet therapeutic needs of patients with rare, chronic and life-threatening diseases in Greece and Cyprus, through innovative therapeutics.
Aligned with this strategic focus, INTEGRIS Pharma actively seeks innovative medicines worldwide and is committed to ensuring direct patient access in the countries where it operates. In recent years, the company has established 18 new collaborations with leading international pharmaceutical companies, building an extensive and diversified product portfolio across multiple therapeutic areas.
The portfolio includes orphan drugs for rare and ultra-rare diseases, innovative and hybrid pharmaceuticals in Oncology and Hematology, as well as first-in-class medical devices for wound healing. More recently, INTEGRIS Pharma has expanded into allergology, offering treatments for both everyday allergic symptoms and severe allergic reactions.
CONTACT
Address: 2, Nikitara Str., GR – 152 32, Chalandri – Athens
- Telephone:210 8778 240
- Website: https://integris.gr/en/
- Email: [email protected]